๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

D07001-Softgel

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 2 trials in our USA and China registers that name D07001-Softgel as an intervention. Synced 24 Sep 2026
2Trials tracked
2Recruiting now
1Lead sponsor
2Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

D07001-Softgel is named as a drug or biological intervention in 2 clinical trials in our USA and China trial registers, 2 of which are recruiting. The lead sponsor is InnoPharmax Inc.. Registered phases: Phase 3 and Phase 2/3. Conditions studied include Biliary Tract Cancer (BTC); Biliary Tract Cancer.

01

Clinical trials of D07001-Softgel

2 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT06622057 D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer (ClinicalTrials.gov ↗)
Biliary Tract Cancer (BTC)
Phase 3 Recruiting InnoPharmax Inc. USA
NCT05065957 Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer (ClinicalTrials.gov ↗)
Biliary Tract Cancer
Phase 2/3 Recruiting InnoPharmax Inc. China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

2 conditions
Condition (as registered)Trials
Biliary Tract Cancer (BTC)1
Biliary Tract Cancer1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
InnoPharmax Inc.2
04

Trials by country register

RegisterD07001-Softgel trials
Clinical trials in USA1
Clinical trials in China1

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how D07001-Softgel works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists D07001-Softgel (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.